Global Digital Biomarkers Industry To Reach over $21,986 Million by 2030

In 2021, the size of the digital biomarkers industry was about $1,851 million, and it will advance at a growth rate of about 32% in the coming years, to reach over $21,986 million by 2030. The high incidence of chronic diseases, along with the technical developments in digital healthcare systems, is expanding the market expansion. 

Digital biomarkers are the basis of precision medicine since they provide concrete evidence of patient consequences. Furthermore, the healthcare system is developing toward a value-based delivery paradigm, which has encouraged the expansion of state-of-the-art technologies, for instance, digital biomarkers. The main goal of emerging this kind of technology is to advance tailor-made care delivery through better analysis of patients’ healthcare information.

The data collection tools accounted for in excess of 90% share in 2021. These tools help in the gathering of data and the extraction of new digital biomarkers that are more accurate, patient-centric, clinically valuable, and more objective than those extracted through conservative research methods, for example, individual rating scales and patient diaries.

The cardiovascular application has suggestively grown regarding revenue, holding a digital biomarkers market share of in excess of 20% in 2021. This is simply owing to a rise in the prevalence of cardiovascular ailments in the global population. As per a government source, they have approximately 32% of the worldwide mortality, with around 18 million persons dying every year.

APAC had the largest demand for biomarkers in 2021, regarding revenue, and it will sustain this in the years to come. In recent years, the snowballing government expenditure on the development of progressive healthcare infra has significantly increased the acceptance of digital biomarkers in the region. The propagation of digital technologies and their growing acceptance in the APAC healthcare industry are driving the industry. Also, the incidence of a large population, rising incidence of chronic ailments, and rampant aging will exponentially upsurge the requirement for digital biomarkers in the future.

North America is the most lucrative region in terms of demand for digital biomarkers. The rising healthcare expenditure, together with the increasing consumer demand for effectual, effective, and unconventional solutions, is assisting in the development of the industry. Furthermore, the high acceptance of digital technologies in the region has significantly powered the acceptance in the industry, and it will continue to do so throughout the years to come.

The acceptance of this concept in Europe is also growing steadily, because of the rising healthcare IT spending, high cognizance of unconventional technological solutions and the willingness to accept them, promising government initiatives, the emergence of startups, mounting penetration of smartphones, profitable funding options, and progressions in internet technology. 

Also, globalization, the increasing elderly population, growing incidence of chronic illnesses, altering lifestyles, and increasing demand for value-based care are responsible for the industry making more and more revenue.

Due to the increasing smartphone usage, the demand for digital biomarkers is on the rise significantly.

Report this Page